| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.084 | 0.2 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.2 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.26 | 0.2 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |